Chlorpheniramine Maleate Tablet
FDA Label NDC 55289-560

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pd-rx Pharmaceuticals, Inc. for the product Chlorpheniramine Maleate (NDC 55289-560). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

16 How Supplied/Storage And Handling

They are supplied as follows:

NDC 55289-560-24 bottles of 24

NDC 55289-560-30 bottles of 30

NDC 55289-560-01 bottles of 100

* Please review the disclaimer below.